Skip to content
Clinical Trials – home

Gornoslaskie Centrum Mwdyczne

Verified siteinfo

Poland Ul. Ziolowa 45/47, 40-635 Katowice, Poland

  • 20 trials recruiting
  • Atrial fibrillation · Acute coronary syndrome · Ischaemic stroke
  • Adults and children

About Specializations

Gornoslaskie Centrum Mwdyczne in Katowice, Poland specialises in clinical trials of conditions such as Atrial fibrillation, Acute coronary syndrome, Ischaemic stroke, Idiopathic pulmonary fibrosis, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiology and Antithrombotic Therapy

The medical center is at the forefront of cardiology research, particularly in the development of innovative antithrombotic therapies for patients with atrial fibrillation (AF) who have undergone percutaneous coronary intervention (PCI). The center's research focuses on optimizing treatment regimens to enhance patient outcomes and minimize risks.

  • Innovative P2Y12 Inhibitor Monotherapy
  • Direct Oral Anticoagulant (DOAC) Strategies
  • Management of Bleeding Risks

Through its pioneering studies, the center is contributing significantly to the understanding of how to balance efficacy and safety in antithrombotic therapy, potentially reshaping standard care practices for AF patients post-PCI.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Ziolowa 45/4740-635 KatowicePoland
Recruiting now
20 trials
Conditions studied
31
Partner status
Verified site

More sites in KatowicePoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

43 clinical trials

Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

A Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Diamedica Therapeutics Inc.

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:Astrazeneca AB

Iron deficiency

Recruiting

Effect of Ferric Carboxymaltose, Ferrous Sulfate, and Sodium Chloride vs Placebo on Physical Performance in Frail Elderly with Iron Deficiency and Cardiovascular Disease

Registered drug
Countries:PolandPoland
  • Participants:65+ years
  • Substances:Sodium Chloride
  • Sponsor:Wroclaw Medical University

A study to evaluate the safety and effectiveness of IKT-001 compared to a placebo in adults with pulmonary arterial hypertension.

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years

A study to evaluate the effectiveness and safety of REGN13335 in adults with pulmonary arterial hypertension

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:HUMAN IGG4 KAPPA MONOCLONAL ANTIBODY AGAINST PLATELET-DERIVED GROWTH FACTOR SUBUNIT B
  • Sponsor:Regeneron Pharmaceuticals Inc.

Dyslipidaemia+1

Recruiting

Study of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

A Study of TGD001 in Patients with Acute Ischemic Stroke to Test Safety and Effectiveness

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium chloride solution 0.9%
  • Sponsor:TargED Biopharmaceuticals B.V.

Fabry's disease

Recruiting

Title: Evaluating low-dose prednisone with standard therapy to improve heart function in patients with cardiac manifestations of Fabry disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Medical University Of Lodz

Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Agencja Badań Medycznych
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.